Glucagon-like Peptide-1 Receptor Agonists and Risk for Anterior Ischemic Optic Neuropathy : A Nationwide Cohort Study.

Ueda P, Svanström H, Söderling J, Pazzagli L, Wintzell V, Eliasson B, Hviid A, Pasternak B

Open source

DOI
10.7326/annals-25-02096
Published
2026 Sep
Container
Annals of internal medicine
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.7326/annals-25-02096,
  title = {Glucagon-like Peptide-1 Receptor Agonists and Risk for Anterior Ischemic Optic Neuropathy : A Nationwide Cohort Study.},
  author = {Ueda P and Svanström H and Söderling J and Pazzagli L and Wintzell V and Eliasson B and Hviid A and Pasternak B},
  year = {2026},
  journal = {Annals of internal medicine},
  doi = {10.7326/annals-25-02096},
  url = {https://doi.org/10.7326/annals-25-02096}
}

RIS

TY  - JOUR
TI  - Glucagon-like Peptide-1 Receptor Agonists and Risk for Anterior Ischemic Optic Neuropathy : A Nationwide Cohort Study.
AU  - Ueda P
AU  - Svanström H
AU  - Söderling J
AU  - Pazzagli L
AU  - Wintzell V
AU  - Eliasson B
AU  - Hviid A
AU  - Pasternak B
PY  - 2026
JO  - Annals of internal medicine
DO  - 10.7326/annals-25-02096
UR  - https://doi.org/10.7326/annals-25-02096
ER  - 

APA

P, U., H, S., J, S., L, P., V, W., B, E., A, H., & B, P. (2026). Glucagon-like Peptide-1 Receptor Agonists and Risk for Anterior Ischemic Optic Neuropathy : A Nationwide Cohort Study.. Annals of internal medicine. https://doi.org/10.7326/annals-25-02096

Source records